Condition: Multiresistant Bacterial Pathogens · Virulent Bacterial Pathogens · Sponsor: University Hospital, Basel, Switzerland
Hypervirulent and multidrug-resistant infections are associated with significant health care costs, substantial morbidity and mortality. Therefore, the rapid recognition of outbreaks and transmissions with hypervirulent and multi-drug resistant pathogen is a key priority for infection control and public health.The main goal is to implement a shared database, connecting human and veterinary microbiology laboratories, which would allow near real-time molecular epidemiology with high spatiotemporal resolution of bacterial pathogens such as transmission and outbreak surveillance between different compartments including humans, animals and the environment in Switzerland. Investigator aims to analyze already collected encoded retrospective datasets of various pathogens by combining epidemiological data and whole genome sequences from pathogens.
This description comes directly from the study's public registry record.
Hans Hirsch, Prof. Dr. · +41 61 32 86697 · hans.hirsch@unibas.ch
Aitana Lebrand, Dr. · Aitana.Lebrand@sib.swiss
Always discuss trial participation with your own doctor first.
| University Hospital Basel | Basel, Switzerland | Recruiting |
| University of Bern | Bern, Switzerland | Recruiting |
| University Hospital Geneva | Geneva, Switzerland | Recruiting |
| University Hospital Lausanne CHUV | Lausanne, Switzerland | Recruiting |
| University of Zurich | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04172025